Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 473 - Heterocyclic compounds containing purine ring systems
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
11/2008
11/20/2008WO2008140302A1 Polymorphic forms of tenofovir disoproxil fumarate
11/20/2008WO2008139539A1 Process for producing valacyclovir
11/20/2008WO2007109661A3 Methods of preparation and resolution of e/z isomers of vinylfuro[2,3-d] pyrimidine and their biological activities
11/20/2008US20080287522 reduced or no emetogenic effects ; benzylated phosphodiesterase 4 inhibitors; e.g. Rolipram, Ariflo, Arofylline; preparation by benzylation using benzyl bromide or a derivative; antiinflammatory agents; to treat autoimmune diseases; cystic fibrosis
11/20/2008US20080287471 4'-Substituted Carbovir And Abacavir-Derivatives As Well As Related Compounds With Hiv And Hcv Antiviral Activity
11/20/2008US20080287468 Purine and imidazopyridine derivatives for immunosuppression
11/20/2008US20080287454 Cxcr4 antagonists
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/19/2008EP1991547A2 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders
11/19/2008EP1417349B1 Novel molecular target for neurotoxicity
11/19/2008CN100434420C Compound inhibiting dipeptidyl peptidase iv
11/18/2008US7452894 Purine derivatives as purinergic receptor antagonists
11/18/2008US7452886 E.g., 6-(6-Chloro-pyridin-3-yloxymethyl)-7-(2,2-dimethyl-propyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile; in particular, cathepsin K inhibitors; osteoporosis; oral, autoimmune and respiratory diseases; osteoarthritis; antiarthritic and antitumor agents; muscular dystrophy; amytrophy; parasiticides
11/18/2008CA2422379C Pyrazole compounds useful as protein kinase inhibitors
11/18/2008CA2400470C Methods for synthesizing 2-chloro-9-(2-deoxy-2-fluoro-.beta.-d-arabinofuranosyl)-9h-purin-6-amine
11/13/2008WO2008137436A1 [6,5]-bicyclic gpr119 g protein-coupled receptor agonists
11/13/2008WO2008135785A1 9- (pyrazol- 3 -yl) - 9h- purine-2 -amine and 3- (pyraz0l-3-yl) -3h-imidaz0 [4, 5-b] pyridin-5-amine derivatives and their use for the treatment of cancer
11/13/2008WO2008024433A3 Haloalkyl-substituted pyrimidinone derivatives
11/13/2008US20080281099 Process for purifying valacyclovir hydrochloride and intermediates thereof
11/13/2008US20080280927 3-(dihydro-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
11/13/2008US20080280926 Phosphodiesterase Inhibitors
11/13/2008CA2684693A1 9-(pyrazol-3-yl)-9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatmentof cancer
11/12/2008EP1989206A2 Inhibitors of e1 activating enzyme
11/12/2008EP1841768B1 Purine derivatives acting as a2a receptor agonists
11/12/2008CN101304977A Nucleic acid base having perfluoroalkyl group and method for producing the same
11/12/2008CN101304748A Tlr agonists
11/11/2008US7449576 potent antagonists of the CCR1 receptor; inflammation; (5-Chloro-2-piperazin-1-yl-phenyl)-phenyl-methanone
11/06/2008WO2008134300A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
11/06/2008WO2008131502A2 Antiviral compounds of the adamantane type
11/06/2008US20080275067 5-methyl-3-phenyl-2-[1-(9H-purin-6-ylamino)-propyl]-3H-quinazolin-4-one; 3-(4-fluoro-phenyl)-5-methyl-2-[1-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ethyl]-3H-quinazolin-4-one; bone-resorption disorder or a cancer of a hematopoietic origin; disorders in which PI3K plays a role in leukocyte function
11/05/2008EP1597258B1 Novel purine derivatives, preparation method thereof, application of same as medicaments, pharmaceutical compositions and novel use
11/05/2008CN100430378C New piperidine derivative
11/04/2008US7446129 Suitable benzylation chemistry is to extract a hydrogen from a PDE4 inhibitor, preferably with a base, then react resulting nucleophilic PDE4 inhibitor with benzylating agent, e.g., benzyl bromide; no emetogenic side effects
10/2008
10/30/2008WO2008129994A1 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
10/30/2008WO2008128428A1 2, 6-dinitrogen-containing substituted purine derivatives, the preparation and uses thereof
10/30/2008WO2008005542A3 Antiviral phosphinate compounds
10/30/2008US20080269260 Using a purine compound; antiallergens; antiinflammatory agents; cognition activators; drug abuse; schizophenia; Alzheimer's disease; Parkinson's disease
10/30/2008US20080269240 Immunomoderator; antiallergens; viricides; anticancer agents; asthma; rhinitis; hepatitis; skin disorders
10/30/2008CA2684638A1 2, 6-dinitrogen-containing substituted purine derivatives, the preparation and uses thereof
10/30/2008CA2680769A1 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
10/29/2008CN101293888A Xanthine derivative, production and use thereof as a medicament
10/28/2008US7442813 Process for producing dioxolane nucleoside analogues
10/23/2008US20080261987 Substituted piperazines
10/23/2008US20080261973 Sulphonamidoaniline Derivatives Being Janus Kinase Inhibitors
10/23/2008US20080261968 Heterobicyclic metalloprotease inhibitors
10/22/2008EP1982985A2 Method for manufacturing a purine derivative
10/22/2008EP1982704A2 New molecular target of neurotoxicity
10/22/2008EP1877411A4 Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv
10/22/2008CN101289449A 2,6-di-nitrogen-containing substituted purine derivatives, preparation method and applications thereof
10/22/2008CN101289448A Method for preparing 1,3,7,9-tetramethyl uric acid
10/22/2008CN100427488C Adenine kind derivative and its synthesis method
10/22/2008CN100427487C Synthesis of purine derivatives
10/22/2008CN100427486C Novel benzimidazole derivatives
10/21/2008US7439359 Antiproliferative agents; antitumor agents; binding to chaperone protein
10/21/2008US7439351 2′ or 3′ -deoxy and 2′, 3′-dideoxy-β-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti-viral agents
10/21/2008US7439345 Supramolecular pairing system, its preparation and use
10/21/2008US7439240 Reversible inhibitors of cysteine proteases S, K, F, L and B; inhibiting Cathepsin S; analgesics; 1-[9-(4-Chlorophenyl)-2-cyano-9H-purin-6-yl]-L-prolinamide for example
10/16/2008WO2008122767A2 2, 6, 9-substituted purine derivatives having anti proliferative properties
10/16/2008WO2007130783A3 Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates
10/16/2008US20080255159 Arthritis, obesity, (non-insulin dependent) diabetes calcitonin-induced osteoporosis; administering allograft transplantation; dipeptidyl peptidase-IV (DPP-IV) inhibitors
10/16/2008US20080253965 Small-Molecule Hsp90 Inhibitors
10/16/2008CA2681529A1 2, 6, 9-substituted purine derivatives having anti proliferative properties
10/15/2008CN101284811A Synthetic method for chiral carbocyclic ring intermediate of abacavir
10/09/2008WO2008121019A1 Antihistaminic and antiallergic agent and a method for the production thereof.
10/09/2008WO2008120205A1 Novel derivatives of purinic and pyrimidinic antiviral agents and use thereof as potent anticancer agents
10/09/2008WO2008049105A3 Sulfamoyl-containing derivatives and uses thereof
10/09/2008US20080249115 small molecule, non-peptide, modulators (e.g., antagonists or agonists) of peptide hormones; treating low blood pressure or an eating disorder
10/09/2008US20080249089 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
10/08/2008EP1976849A2 Compounds for the treatment of inflammatory disorders
10/08/2008CN101282977A Xanthine derivatives as selective hm74a agonists
10/08/2008CN101282976A Xanthine derivatives as selective HM74A agonists
10/07/2008US7432274 e.g., R)-9-[2-(Stearoyloxymethyl)- and (R)-9-[2-(Myristoyloxymethyl)-4-(L-valyloxy)butyl]guanine; treatment or prophylaxis of viral infections such as those caused by Varicella zoster, Herpes, Epstein-Barr SIV, HIV-1 or HIV-2.
10/07/2008US7432272 Pharmacokinetic properties, including improved oral bioavailability, greater potency and extended effective drug biological half-life in vivo; inhibiting RNA-dependent RNA polymerase, infections
10/07/2008US7432264 Antibacterial compounds such as (S)-2-cyano-1-(trans-4-(5-nitro-2-pyridylamino)cyclohexylamino )acetylpyrrolidine; activity against Gram-negative and Gram-positive pathogens, including a methicillin-resistant S. aureus strain
10/07/2008CA2444071C Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
10/02/2008WO2008118468A1 Heterocyclic compounds and their uses
10/02/2008WO2008117796A1 Novel mutilin derivatives
10/02/2008WO2008116914A1 Purinyl derivatives and their use as potassium channel modulators
10/02/2008WO2008116911A1 Purinyl derivatives and their use as potassium channel modulators
10/02/2008WO2008116910A1 Purinyl derivatives and their use as potassium channel modulators
10/02/2008WO2008116909A1 Purinyl derivatives and their use as potassium channel modulators
10/02/2008WO2008082440A3 Fluorescent nucleoside analogues
10/02/2008WO2008051826A3 Purines as pkc-theta inhibitors
10/02/2008WO2007142755A3 Purine analogs
10/02/2008US20080242683 Antiinflammatory agents; chronic obstructive pulminary disease
10/02/2008CA2682019A1 Purinyl derivatives and their use as potassium channel modulators
10/01/2008EP1975157A1 METHOD FOR PRODUCTION OF HETEROAROMATIC RING COMPOUND HAVING N-Rf GROUP
10/01/2008EP1974732A1 Therapeutic agent for neurodegenerative disease
10/01/2008CN101274934A Medicaments with HM74a receptor activity
09/2008
09/30/2008US7429595 Inhibiting cyclin-dependent kinase complexes including cdk1/cyclin B, cdk2/cyclin E and cdk4/cyclin D1; preventing apoptosis
09/30/2008CA2417417C Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
09/30/2008CA2195856C Substituted o6-benzylguanines and use thereof
09/25/2008WO2008116129A2 Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitors
09/25/2008WO2008115262A2 Hsp90 inhibitors containing a zinc binding moiety
09/25/2008WO2008114819A1 Novel adenine compound
09/25/2008WO2008114817A1 Novel adenine compound
09/25/2008WO2008114008A1 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7 ) modulators
09/25/2008WO2008114006A1 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7) modulators
09/25/2008WO2008011007A3 Selective antagonists of a2a adenosine receptors
09/25/2008US20080234297 HSP90 Inhibitors Containing a Zinc Binding Moiety
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 120